Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,1735696,enhancement ratios,"Their in vitro enhancement ratios are 2.00 and 1.75, respectively, compared with those of KIH-802, MISO and SR-2508, 1.77, 1.72 and 1.72, respectively, at each dose of 1 mM for EMT6/KU single cell.","Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1735696/),,2.00,188258,DB00551,Acetohydroxamic Acid
,1735696,enhancement ratios,"Their in vitro enhancement ratios are 2.00 and 1.75, respectively, compared with those of KIH-802, MISO and SR-2508, 1.77, 1.72 and 1.72, respectively, at each dose of 1 mM for EMT6/KU single cell.","Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1735696/),,1.75,188259,DB00551,Acetohydroxamic Acid
,1735696,enhancement ratios,"Their in vitro enhancement ratios are 2.00 and 1.75, respectively, compared with those of KIH-802, MISO and SR-2508, 1.77, 1.72 and 1.72, respectively, at each dose of 1 mM for EMT6/KU single cell.","Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1735696/),,1,188260,DB00551,Acetohydroxamic Acid
,1735696,enhancement ratios,"Their in vitro enhancement ratios are 2.00 and 1.75, respectively, compared with those of KIH-802, MISO and SR-2508, 1.77, 1.72 and 1.72, respectively, at each dose of 1 mM for EMT6/KU single cell.","Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1735696/),,1.72,188261,DB00551,Acetohydroxamic Acid
,649302,biologic half-life,Studies performed in human subjects indicated that AHA is rapidly absorbed from the gastrointestinal tract and has a biologic half-life of 5 to 10 hr in subjects with normal renal function.,Pharmacokinetics of acetohydroxamic acid. Preliminary investigations. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/649302/),h,5 to 10,199338,DB00551,Acetohydroxamic Acid
